FDA Approves Mounjaro for Cardiovascular Risk Reduction in Adults with Type 2 Diabetes
"Mounjaro, already a leading medication for type 2 diabetes, now carries FDA approval to reduce the risk of major adverse cardiovascular events, marking a significant expansion of its therapeutic role…